Innoviva Inc

NASDAQ:INVA  
11.70
-0.18 (-1.56%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Innoviva, Inc. Stock, NASDAQ:INVA

1350 Old Bayshore Highway, Suite 400, Burlingame, California 94010
United States of America
Phone: +1.650.238.9600
Number of Employees: 6

Description

Innoviva, Inc. is engaged in the development, commercialization, and financial management of bio-pharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate; and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Burlingame, CA.